Search

Wendell Wierenga Phones & Addresses

  • Kalamazoo, MI

Publications

Us Patents

Process For Therapeutic Treatment

View page
US Patent:
45902119, May 20, 1986
Filed:
May 30, 1984
Appl. No.:
6/615661
Inventors:
John J. Voorhees - Ann Arbor MI
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 3117
US Classification:
514594
Abstract:
This invention relates to a new method of therapy comprising the administration of a pro-drug to a human or animal, said pro-drug being a compound formed by a therapeutic compound chemically combined with another moiety by a photocleavable bond and irradiating the diseased area with ultraviolet radiation in an amount sufficient to cleave the bond and release the therapeutic compound in a therapeutically effective amount. Specifically disclosed are pro-drugs which are cleaved to therapeutically active medications which are anti-proliferative and anti-inflammatory compounds and the treatment of inflammatory and/or proliferative skin diseases therewith.

1,2,8,8A-Tetrahydrocyclopropa(C)Pyrrolo(3,2-E)-Indol-4-(5H)-Ones And Related Compounds

View page
US Patent:
49122274, Mar 27, 1990
Filed:
Aug 7, 1986
Appl. No.:
6/894314
Inventors:
Robert C. Kelly - Augusta MI
Martha A. Warpehoski - Kalamazoo MI
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
C07D48708
US Classification:
548421
Abstract:
1,2,8,8a-Tetrahydrocyclopropa[3]pyrrolo(3,2-e)indol-4(5H)-ones, and related compounds of formulas I and intermediate therefor II ##STR1## wherein R. sub. 2, R. sub. 2 ', R. sub. 3, R. sub. 5, R. sub. 50 and X are as defined in the specification, e. g. , (7bR,8aS)-1,2,8,8a-tetrahydro-7-methyl-2-[[5-(((1H-indol-2-yl)carbonyl)ami no)-1H-indol-2-yl]carbonyl]cyclopropa[pyrrolo[3,2-e]indol-4(5H)-one (U-71,184), as purified, and its racemic form (U-68,415), and related compounds, are useful as ultraviolet light absorbers and as antibacterials. The lead compounds are useful as antitumor drug compounds in standard laboratory animal tests.

Process For Therapeutic Treatment

View page
US Patent:
43024564, Nov 24, 1981
Filed:
Aug 4, 1980
Appl. No.:
6/174990
Inventors:
John J. Voorhees - Ann Arbor MI
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
The Regents of the University of Michigan - Ann Arbor MI
International Classification:
A61K 31705
A61K 31505
C07J 4100
US Classification:
424251
Abstract:
This invention relates to a new method of therapy comprising the administration of a pro-drug to a human or animal, said pro-drug being a compound formed by a therapeutic compound chemically combined with another moiety by a photocleavable bond and irradiating the diseased area with ultraviolet radiation in an amount sufficient to cleave the bond and release the therapeutic compound in a therapeutically effective amount. Specifically disclosed are pro-drugs which are cleaved to therapeutically active medications which are anti-proliferative and anti-inflammatory compounds and the treatment of inflammatory and/or proliferative skin diseases therewith.

Process For Treating Hypertension

View page
US Patent:
43082726, Dec 29, 1981
Filed:
Oct 3, 1980
Appl. No.:
6/193573
Inventors:
Wendell Wierenga - Kalamazoo MI
Harvey I. Skulnick - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 31505
US Classification:
424251
Abstract:
A process for treating hypertension comprising the systemic administering to a hypertensive subject a compound of the formula: ##STR1## wherein R. sub. 1 is --NH. sub. 2. R. sub. 2 is chloro, bromo, or iodo. R. sub. 3 is hydrogen or fluorine. R. sub. 4 is hydrogen or fluorine, and R. sub. 5 is hydrogen, fluorine, or CH. sub. 3 ; or the salts thereof in association with a pharmaceutical carrier.

1,2,8,8A-Cyclopropa?c!Benzo?1,2,-B:-4,3-B'!Dipyrrol-4(5H)-Ones

View page
US Patent:
44243650, Jan 3, 1984
Filed:
Jun 22, 1982
Appl. No.:
6/391055
Inventors:
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
C07C48702
A01N 4338
US Classification:
548421
Abstract:
Novel antibacterially active compound, 1,2,8,8a-cyclopropa�c!benzo�1,2-b:-4,3-b'!dipyrrol-4(5H)-one, prepared by a novel chemical process. This compound, as well as antibacterially-active intermediates, can be used to eradicate or control susceptible bacteria, for example B. subtilis, K. pneumonia, S. lutea, S. aureus, and M. avium.

Substituted Alkoxy Carbonyl-3-Oxo-.Alpha.-Phthalimido-5-Isoxozolidineacetic Acids

View page
US Patent:
42752140, Jun 23, 1981
Filed:
Jul 31, 1979
Appl. No.:
6/062459
Inventors:
Robert C. Kelly - Kalamazoo MI
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
C07D41306
C07D26104
US Classification:
548243
Abstract:
Analogs of tricholomic acids and process for preparing them.

Processes For The Preparation Of 6-Aryluracils

View page
US Patent:
45784663, Mar 25, 1986
Filed:
Sep 17, 1984
Appl. No.:
6/651495
Inventors:
Harvey I. Skulnick - Kalamazoo MI
Herman W. Smith - Kalamazoo MI
Robert J. Smith - Kalamazoo MI
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
C07D23910
C07D26506
US Classification:
544309
Abstract:
This invention relates to the use of 6-aryluracils as antiinflammatory and antiarthritic agents and also to both novel intermediates and novel processes for the preparation of selected 6-aryluracils.

Process For Therapeutic Treatment

View page
US Patent:
42358876, Nov 25, 1980
Filed:
Apr 13, 1977
Appl. No.:
5/787230
Inventors:
John J. Voorhees - Ann Arbor MI
Wendell Wierenga - Kalamazoo MI
Assignee:
The Upjohn Company - Kalamazoo MI
International Classification:
A61K 31705
C07J 4100
US Classification:
424180
Abstract:
This invention relates to a new method of therapy comprising the administration of a pro-drug to a human or animal, said pro-drug being a compound formed by a therapeutic compound chemically combined with another moiety by a photocleavable bond and irradiating the diseased area with ultraviolet radiation in an amount sufficient to cleave the bond and release the therapeutic compound in a therapeutically effective amount. Specifically disclosed are pro-drugs which are cleaved to therapeutically active medications which are anti-proliferative and anti-inflammatory compounds and the treatment of inflammatory and/or proliferative skin diseases therewith.
Wendell Wierenga from Kalamazoo, MI Get Report